jueves, 14 de junio de 2012

Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence|SAMHSA

open here to download the file ►
Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence|SAMHSA


Gives an overview of extended-release injectable naltrexone (Vivitrol), a treatment for people with opioid dependence. Discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit from this treatment.
Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence

Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence

No hay comentarios:

Publicar un comentario